Dow gives back 0.2%. Watch these stock charts: NKE, S, CREE >>> READ MORE


Add Roche to Your List of Ebola Stocks, But …

Ebola stocks have doled out some big gains to savvy traders this year, but investors looking for Roche (RHHBY) to do the same may want to rethink their expectations. More 

Gilead Stock Will Rise on Sovaldi® Sales

Gilead's breakthrough Hepatitis C drug, Sovaldi®, will drive revenue and profits for the rest of 2014 and into 2015. More 

Roche Proves You Can’t Judge a Book by Its Cover

Roche stock may not be an NYSE or NASDAQ-listed equity, but when you look at the details, RHHBY is plenty investment-worthy. More 

3 Huge Healthcare Trends Can Fatten Your Portfolio

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More 

AstraZeneca Probed Over Heart-Drug Trial

British drug maker AstraZeneca says the U.S. Department of Justice is investigating a clinical trial of its Brilinta heart drug. More 

Our Stock Earnings Rundown – HSY KMB DFS SHW LUV TMO AMGN

A big week for earnings and dividend increases includes these 8 stocks in our portfolio. More 

Roche’s Breast Cancer Drug Approval Is Just the Beginning

It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape. More